HSD17B10 and Alzheimer disease: Experimental results revealed overexpression of 17β-HSD10 especially in cortical or hippocampal regions of AD patients when compared to age-matched controls [8, 9] which is also reflected by increased concentrations in cerebrospinal fluid (CSF) [10–12].